Orange Book product
MOMETASONE FUROATE 0.05MG/SPRAY
Orange Book ANDA 211706 · NASPRESS PHARMACEUTICAL CO LTD · Prescription
Key facts
| Proprietary name | MOMETASONE FUROATE |
|---|---|
| Active ingredients | MOMETASONE FUROATE |
| Strength | 0.05MG/SPRAY |
| Dosage form | SPRAY, METERED |
| Route | NASAL |
| Application | ANDA211706 |
| Applicant holder | NASPRESS PHARMACEUTICAL CO LTD |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AB |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | May 15, 2025 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.